Public announcement · US Preventive Services Task Force · 2021-04-13
A 2021 review examined screening in adults living in the community who had no signs of deficiency.
The US Preventive Services Task Force concluded in April 2021 that the evidence was insufficient to judge the balance of benefits and harms of routine vitamin D screening in adults without symptoms. The question was whether finding and treating low levels through screening improved health.
Its review concerned non-pregnant adults living in the community who had neither signs of deficiency nor a condition already calling for vitamin D treatment. The panel also noted variation between laboratory methods and uncertainty over the blood level used to define deficiency.
The task force found no studies that directly measured the benefits or harms of screening. It did find research on treating people with low test results, but thresholds for defining a low level differed across the studies.
